| Tailandia | España | Turquía | |
| Trasplante de médula ósea | de $50,000 / 1,850,000฿ | de $71,782 / 2,655,934฿ | de $36,000 / 1,332,000฿ |
| Trasplante autólogo de médula ósea | de $40,000 / 1,480,000฿ | de $40,000 / 1,480,000฿ | de $31,500 / 1,165,500฿ |
| Trasplante alogénico de médula ósea de un donante no emparentado | de $150,000 / 5,550,000฿ | de $150,000 / 5,550,000฿ | de $80,000 / 2,960,000฿ |
| Trasplante alogénico de médula ósea de un donante emparentado | de $95,000 / 3,515,000฿ | de $13,886 / 513,782฿ | de $65,000 / 2,405,000฿ |
| Quimioterapia para el cáncer de mama | de $3,000 / 111,000฿ | de $3,500 / 129,500฿ | de $1,200 / 44,400฿ |
Bookimed no añade cargos extra a los precios de los tratamientos de Leucemia linfoblástica aguda. Las tarifas proceden de las listas de precios oficiales de las clínicas. Pagará directamente en la clínica por su tratamiento a su llegada al país.
Bookimed está comprometido con su seguridad. Solo trabajamos con las clínicas que mantienen altos estándares internacionales en el tratamiento de Leucemia linfoblástica aguda y cuentan con las licencias necesarias para atender a pacientes internacionales en todo el mundo.
Bookimed ofrece asistencia experta gratuita. Un coordinador médico personal le apoya antes, durante y después de su tratamiento, resolviendo cualquier problema. Nunca estará solo en su viaje médico de tratamiento de Leucemia linfoblástica aguda.
La Dra. Litleaungdej es una hematóloga formada en la Universidad de Thammasat, especializada en trastornos sanguíneos, incluida la leucemia linfoblástica aguda.
El Dr. Surasit Saleh Issarachai es un triple especialista en el Hospital Bumrungrad, enfocado en cuidados oncológicos, hematológicos y trasplantes de médula ósea.
Leukemia treatment in Thailand is safe for foreigners due to JCI-accredited facilities and US-standard protocols. Leading hospitals like Bumrungrad International maintain Global Healthcare Accreditation for international safety. Specialists often hold Thai Board of Hematology certification and global fellowships. Advanced therapies include CAR T-cell and haploidentical stem cell transplants.
Bookimed Expert Insight: Thailand’s safety for leukemia patients is driven by extreme specialization within private centers. Bumrungrad International alone manages 70 separate departments and 1,300 doctors. This scale allows hematologists like Dr. Surasit Saleh Issarachai to focus exclusively on bone marrow transplants. High patient volumes lead to refined clinical pathways and improved survival outcomes.
Patient Consensus: Patients emphasize the need to verify that insurance covers oncology in Thailand. They suggest coordinating follow-up care with home-country specialists before starting treatment abroad.
Thailand offers advanced therapies for Acute Lymphoblastic Leukemia (ALL) comparable to Western centers. Major facilities provide allogeneic and autologous stem cell transplants. They utilize personalized treatments like CAR NK-cell therapy. Leading hospitals in Bangkok maintain Joint Commission International accreditation and use molecular diagnostics for precision staging.
Bookimed Expert Insight: While many countries offer basic hematology, Thailand stands out for its high-volume diagnostic infrastructure. Bumrungrad International Hospital alone serves 1 million patients annually. Their sheer patient volume often leads to faster diagnostic turnaround for complex cytogenetic studies compared to Western public systems. This allows for quicker initiation of targeted ALL protocols.
Patient Consensus: Patients note that Bangkok hospitals provide excellent standard-of-care hematology and supportive services. Most emphasize verifying that a facility has a dedicated transplant unit and ICU backup before starting intensive induction therapy.
Bumrungrad International Hospital and major university centers like Siriraj Hospital lead Thailand in leukemia and bone marrow transplant care. These facilities offer JCI-accredited environments. They utilize advanced techniques like haploidentical transplants and CAR NK cell therapy for acute lymphoblastic leukemia. International patients often choose Bangkok for specialized hematology oncology teams.
Bookimed Expert Insight: Thailand’s private sector is dominated by Bumrungrad, which treats over 1,000,000 patients annually from 190 countries. While public university hospitals lead in research, private facilities offer significantly faster donor workup speeds. For acute cases where chemotherapy response is urgent, private centers like Bumrungrad provide immediate hematology oncology coordination. This speed is critical for conditions like adult ALL where treatment timing determines survival.
Patient Consensus: Patients emphasize that transplant success depends more on the facility's dedicated isolation ward and blood bank than hospital brand names. Travelers note that large Bangkok hospitals provide much smoother logistic support for those requiring long-term post-transplant monitoring.
Acute lymphoblastic leukemia therapy for international patients in Thailand typically spans 2 to 3 years. The initial intensive phase requires a 3 to 6-month relocation. This period covers induction and consolidation cycles. Maintenance therapy follows and can often be managed with periodic travel or local coordination.
Bookimed Expert Insight: Data shows that top Thai facilities like Bumrungrad International Hospital manage over 500,000 international cases annually. This high volume allows centers to start induction chemotherapy within 48 to 72 hours of arrival. While many patients plan for a short trip, specialists like Dr. Surasit Saleh Issarachai emphasize that induction success determines if a patient needs a complex bone marrow transplant.
Patient Consensus: Patients note that care starts almost immediately after records are reviewed. Many emphasize the need to prepare for unexpected stays since fevers or low blood counts often delay the original schedule.
Thai hematology centers provide comprehensive support including palliative care, symptom management, and psychological counseling. Facilities like Bumrungrad International Hospital offer JCI-accredited care with specialized oncology teams. These services address physical side effects like nausea while providing emotional resources for families during intensive leukemia treatments.
Bookimed Expert Insight: While many focus on doctors, our data shows the value of nurse-led support. Hospitals like Bumrungrad treat over 1 million patients annually with 1,300 physicians. This high volume means nursing teams have refined protocols for managing chemotherapy side effects. Patients should request a direct nurse contact early to manage symptoms at home.
Patient Consensus: Patients often find that small practical details like hydration tips and soft food suggestions matter most. Many emphasize that informal support from family remains the primary emotional buffer during long hospital stays.